Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Benralizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis (EGPA) Study (BITE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03010436
Recruitment Status : Unknown
Verified May 2017 by Michael Wechsler, National Jewish Health.
Recruitment status was:  Recruiting
First Posted : January 5, 2017
Last Update Posted : May 9, 2017
Sponsor:
Collaborator:
AstraZeneca
Information provided by (Responsible Party):
Michael Wechsler, National Jewish Health

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : December 2018
  Estimated Study Completion Date : December 2018